The Journal of American Medical Association published a study by a Greek doctor on Fish Oil. This report was picked up by media which gave it different spins.
Brian Williams of NBC with Robert Bazell gave more balanced reporting.I suggest you see that Video. Headlines in Bloomberg,Forbes were misleading.
So what's the truth?
During 1999-2005, Mochida Corp. of Japan conducted a very large study of Japanese people with Epadel and w/o Epadel. Epadel is over 90% EPA with almost no DHA.
FYI most of Fish oil Omega3 sold have high% of DHA--which raises LDL etc.Even Lovaza and Triplix -presription drugs have high% of DHA and their labeling says that it raises LDL.Recently FDA asked Lovaza to state that IT MAY CAUSE ATRIAL FIBRILLATION.
Back to the JELIS study:
The JELIS STUDY found that Epadel reduces heart attacks and heart deaths significantly.
FDA approved a new drug VASCEPA 6 weeks ago.This drug reduces bad LIPID while lowering trigylcerides significantly.
The only side effect reported was joint pain in some patients—less than 2%.
The FDA asked Amarin to conduct a large-scale study at $125 million over 4 to 5 years to study if VASCEPA lowers heart attacks or deaths. Dr. Deepak Bhatt of Harvard is doing this VASCEPA study for 8,000 persons in the U.S. and Europe, so wait for results in 2015 or 2016.
Now Vascepa is recommended for Patients with VERY HIGH trigylcerides, more than 500mg. Next year, the FDA may approve Vascepa for people with more than 200mg trigylcerides.
What should you do if your trigylcerides are below 200mg?
Take generic Lipitor or Crestor.
You can take Fish Oil supplements, but you MUST GET YOUR BLOOD checked once a year and discuss Fish oil OMEGA 3 with your doctor.
NBC—Robert Bazell quoted a Harvard Professor: It does not harm you but may not help you. So please listen to that video.
Brian Williams and I grew up in same area: Elmira, Corning, NY.